American Heart Association/American Stroke Association Newsroom
Latest News Releases
Special issue on global disparities in management of cardiovascular disease illustrates need for global outreach and leadership
Results from studies featured in the November issue of the journal Circulation: Cardiovascular Quality and Outcomes focus on the disparities in cardiovascular care found globally, emphasizing the importance of the American Heart Association’s leadership as the world’s leading voluntary health organization devoted to fighting cardiovascular disease.
Starting this week, tobacco companies must run court-ordered ads telling the truth about their lethal products
Starting Nov. 26, the major U.S. tobacco companies must run court-ordered newspaper and television advertisements that tell the American public the truth about the deadly consequences of smoking and secondhand smoke, as well as the companies’ intentional design of cigarettes to make them more addictive.
Aramark serves up 14 percent reduction in sodium through healthy menu innovation as new American Heart Association hypertension guidelines emphasize lifestyle modifications
Aramark, the largest U.S. food service company serving two billion meals each year and the American Heart Association, the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke, report significant strides in delivering healthier options across the menus it serves to millions in colleges and universities, hospital cafes and workplace locations.
Using Real Patient Stories, New PSA Campaign Urges Americans to Bring High Blood Pressure Under Control
New York, NY, November 16, 2017: Today the American Heart Association (AHA), American Stroke Association (ASA), and the American Medical Association (AMA) announced a new public service awareness (PSA) campaign in partnership with the Ad Council. The...
The American Heart Association and Lawrence Livermore National Laboratory (LLNL) have formed a strategic business relationship to overcome the burden of drug discovery, cost and access.